Antipodean Advisors’s Herbalife HLF Stock Holding History

Antipodean Advisors’s Portfolio HLF Stock Details HLF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-274,600	Closed	-$12.2M	–	11
2021 Q1	$12.2M	Sell	274,600 -100,400	-27%	-$4.95M	3.77%	6
2020 Q4	$18M	Hold	375,000	–	–	5.06%	6
2020 Q3	$17.5M	Hold	375,000	–	–	6.4%	5
2020 Q2	$16.9M	Buy	375,000 +175,000	+88%	+$6.8M	7.79%	6
2020 Q1	$5.83M	Hold	200,000	–	–	5.38%	6
2019 Q4	$9.53M	Sell	200,000 -47,000	-19%	-$2.04M	5.45%	7
2019 Q3	$9.35M	Buy	247,000 +87,000	+54%	+$3.4M	7.8%	6
2019 Q2	$6.84M	Sell	160,000 -40,000	-20%	-$1.89M	8.32%	6
2019 Q1	$10.6M	Sell	200,000 -22,000	-10%	-$1.26M	7.53%	4
2018 Q4	$13.1M	Buy	222,000 +24,000	+12%	+$1.32M	24.78%	2
2018 Q3	$10.8M	Buy	+198,000	New	+$10.9M	13.39%	3
2014 Q1	–	Sell	-1,741,626	Closed	-$68.5M	–	21
2013 Q4	$68.5M	Buy	1,741,626 +888,626	+104%	+$30.8M	5.93%	8
2013 Q3	$29.8M	Buy	+853,000	New	+$26.4M	3.1%	12

Other funds holding HLF

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ROIC

Route One Investment Company San Francisco, California $2.35B AUM 11.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Alua Capital Management New York $1.13B AUM 8.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DVI

Deccan Value Investors Greenwich, Connecticut $84.6M AUM 57.32% 1-Year Est. Return

BCM

Bronte Capital Management Bondi Junction, Australia $1.01B AUM 47.99% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

Antipodean Advisors's HLF Position: Q2 2021 in Review

Antipodean Advisors sold out of Herbalife (HLF) in Q2 2021, closing a stake of 274,600 shares — an estimated $12.2M sold.

Antipodean Advisors first reported a position in HLF in Q3 2013 and held it in 13 quarters. The position peaked at $68.5M in Q4 2013. 248 funds tracked by Wall St. Rank hold HLF as of Q2 2021.

Antipodean Advisors reported no remaining Herbalife position as of Q2 2021 after selling out during the quarter.
Antipodean Advisors sold 274,600 Herbalife shares in Q2 2021, an estimated $12.2M.
Antipodean Advisors first reported a position in Herbalife in Q3 2013 and held it in 13 quarters.
Antipodean Advisors's Herbalife position peaked at $68.5M in Q4 2013.
248 funds tracked by Wall St. Rank held Herbalife as of Q2 2021.

Based on Antipodean Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.